These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31235764)

  • 1. Simultaneous assay for protease activities of hepatitis C virus and human immunodeficiency virus based on fluorescence detection.
    Kabashima T; Tonooka K; Takada M; Kai M; Shibata T
    Sci Rep; 2019 Jun; 9(1):9150. PubMed ID: 31235764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective and facile assay of human immunodeficiency virus protease activity by a novel fluorogenic reaction.
    Yu Z; Kabashima T; Tang C; Shibata T; Kitazato K; Kobayashi N; Lee MK; Kai M
    Anal Biochem; 2010 Feb; 397(2):197-201. PubMed ID: 19852926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.
    Matayoshi ED; Wang GT; Krafft GA; Erickson J
    Science; 1990 Feb; 247(4945):954-8. PubMed ID: 2106161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Bio-Layer Interferometry-Based Protease Assay Using HIV-1 Protease as a Model.
    Miczi M; Diós Á; Bozóki B; Tőzsér J; Mótyán JA
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34205716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graphene oxide-based biosensing platform for rapid and sensitive detection of HIV-1 protease.
    Zhang Y; Chen X; Roozbahani GM; Guan X
    Anal Bioanal Chem; 2018 Sep; 410(24):6177-6185. PubMed ID: 29968105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a mammalian cell-based assay for monitoring the HIV-1 protease activity.
    Rajakuberan C; Hilton BJ; Wolkowicz R
    Methods Mol Biol; 2012; 903():393-405. PubMed ID: 22782834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
    Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
    J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic activity of human immunodeficiency virus type 1 protease in crowded solutions.
    Maximova K; Wojtczak J; Trylska J
    Eur Biophys J; 2019 Oct; 48(7):685-689. PubMed ID: 31463540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant fusion protein-based, fluorescent protease assay for high throughput-compatible substrate screening.
    Bozóki B; Gazda L; Tóth F; Miczi M; Mótyán JA; Tőzsér J
    Anal Biochem; 2018 Jan; 540-541():52-63. PubMed ID: 29122614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
    Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
    Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic profiling of substrate binding response to multidrug-resistant mutations in HIV-1 protease: Implication for combating drug resistance.
    Lv Y; Li J; Fang J; Jiao X; Yan L; Shan B
    J Mol Graph Model; 2017 Jun; 74():83-88. PubMed ID: 28371730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities between Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Genetic and Phenotypic Protease Quasispecies Diversity.
    Martinez MA; Nevot M; Jordan-Paiz A; Franco S
    J Virol; 2015 Oct; 89(19):9758-64. PubMed ID: 26178979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high throughput assay of the hepatitis C virus nonstructural protein 3 serine proteinase.
    Kakiuchi N; Nishikawa S; Hattori M; Shimotohno K
    J Virol Methods; 1999 Jun; 80(1):77-84. PubMed ID: 10403679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography.
    Sudo K; Inoue H; Shimizu Y; Yamaji K; Konno K; Shigeta S; Kaneko T; Yokota T; Shimotohno K
    Antiviral Res; 1996 Aug; 32(1):9-18. PubMed ID: 8863991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Vif-derived peptide inhibits drug-resistant HIV proteases.
    Blumenzweig I; Baraz L; Friedler A; Danielson UH; Gilon C; Steinitz M; Kotler M
    Biochem Biophys Res Commun; 2002 Apr; 292(4):832-40. PubMed ID: 11944889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production.
    Baraz L; Friedler A; Blumenzweig I; Nussinuv O; Chen N; Steinitz M; Gilon C; Kotler M
    FEBS Lett; 1998 Dec; 441(3):419-26. PubMed ID: 9891983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous assay of the hydrolytic activity of human immunodeficiency virus-1 protease.
    Tyagi SC; Carter CA
    Anal Biochem; 1992 Jan; 200(1):143-8. PubMed ID: 1595889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity.
    Konvalinka J; Litterst MA; Welker R; Kottler H; Rippmann F; Heuser AM; Kräusslich HG
    J Virol; 1995 Nov; 69(11):7180-6. PubMed ID: 7474139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
    Yu FH; Wang CT
    Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.